Douglas J Swirsky Insider Trading $RNN Ocuphire Pharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Douglas J Swirsky.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Douglas J Swirsky. Douglas J Swirsky is Director in Fibrocell Science, Inc. ($FCSC) and Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and Chief Financial Officer in GENVEC INC ($GNVC) and President & CEO in GENVEC INC ($GNVC) and President and CEO in GENVEC INC ($GNVC) and President and CEO in REXAHN PHARMACEUTICALS, INC. ($RNN) and President and CFO in REXAHN PHARMACEUTICALS, INC. ($RNN) and Director in Cellectar Biosciences, Inc. ($CLRB) and Director in NeuroBo Pharmaceuticals, Inc. ($GEMP).

Douglas J Swirsky in Ocuphire Pharma, Inc.

Trading Symbol: RNN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: President and CEO, President and CFO
Holdings: 50,000 shares
Current Value: $9,000
Latest Transaction: Jan 30 2019
$RNN Market Capitalization: $41.78M
$RNN Previous Close: $0.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Douglas J Swirsky in Ocuphire Pharma, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLRB, FCSC, GNVC, NRBO, RNN, GTA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 30 2019	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CEO	Buy	P	0.63	50,000	31,720	50,000	0 to 50 K
Nov 16 2018	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CEO	Option Exercise	A	1.09	500,000	545,000	500,000
Jan 04 2018	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CFO	Option Exercise	A	2.10	250,000	525,000	250,000

Page: 1